Microneedle Drug Delivery Systems Market Size & Share, by Type (Solid, Hollow, Dissolving, Coated); Material (Silicon, Metal, Polymer); Application (Dermatology, Drug Delivery, Pain Management, Cancer Therapy, Vaccine Delivery); End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Academic Institutions, Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4258
  • Published Date: Feb 17, 2023
  • Report Format: PDF, PPT

Global Microneedle Drug Delivery Systems Market Definition

Microneedle patches are micron-scaled medical devices used to administer drugs, vaccines, and other therapeutic agents. Initially, microneedles were explored for transdermal drug delivery applications with their extended use for the intraocular, vaginal, vascular, gastrointestinal, cardiac, and intracochlear delivery of drugs. The construction of microneedles involves various methods such as photolithographic processes or micro molding. Microneedles are usually applied through even a single needle. It can be prepared as a low-cost patch that is simple for patients to apply for the delivery of biomacromolecules.

The microneedle drug delivery device is made in such a way with a mechanism of hundreds of microneedles in a small patch. This system helps in the direct delivery of drugs to the epidermis without touching the blood vessels and nerve fibers that are present in the derma layers. The factors fuelling the growth of the microneedle drug delivery system are expanding with the demand for safer substitutes for conventional hypodermic injections and rising research and development initiatives by the government.

Global Microneedle Drug Delivery Systems Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~ USD 700 Million

Forecast Year Market Size (2035)

~ USD 1300 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Global Microneedle Drug Delivery Systems Market Size, Forecast, and Trend Highlights Over 2023 – 2035

The global microneedle drug delivery systems market is estimated to garner a revenue of ~USD 1300 million by the end of 2035 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of ~USD 700 million in the year 2022. The market is estimated to grow on the back of the increasing prevalence of chronic conditions such as diabetes, cancer, heart disease, and stroke. Over the past ten years, there has also been an increase in other lifestyle-related illnesses such as Alzheimer's disease, chronic kidney disease, and chronic lung disease. According to the Centers for Disease Control and Prevention, four out of ten people in the US have two or more chronic diseases, and six out of ten adults in the country have at least one. Furthermore, according to statistics, in 2021, around 530 million adults aged 20-79 have been diagnosed with diabetes globally, a figure projected to rise to 640 million by 2030 and 780 million by the end of 2040.


Additionally, the non-invasive method of microneedle patch immunization has been thoroughly researched. The World Health Organization has ranked vaccine reluctance as one of the top ten hazards to global health. According to a recent study conducted in October 2020, 53.1% of the people under that study chose not to get vaccinated or were unsure if they should get vaccinated. Fear of needles, pain and side effects are the usual causes of vaccine reluctance. The market is anticipated to expand owing to the rising demand for microneedle patches that don't require needles or the effect of pain associated with it.

Global Microneedle Drug Delivery Systems Market: Growth Driver and Challenges

Growth Drivers

  • Growth of the Healthcare Industry – Microneedle drug delivery systems offer various advantages compared to conventional hypodermic injections such as enhanced efficacy, self-administration, and quick onset of action. The increasing research and development by large firms and business organizations in microneedles to improve their stability is estimated to fuel the growth of the microneedle drug delivery systems market in the coming years. According to statistics, the United States healthcare industry was valued at around USD 800 billion in 2021.

  • Rising Cases of Cancer – According to data from the Centers for Disease Control and Prevention, approximately 1,752,735 new cancer cases were diagnosed in the United States in 2019 and approximately 599,589 people died of cancer.

  • Increased Research and Development Expenditure – According to the World Bank data, the worldwide research and development expenditure as a ratio to Gross Domestic Product (GDP) was around 2.33% in 2019, which increased to 2.63% in 2020.

  • Increasing Rate of Obesity in Population – According to the most recent data, the obesity rate among citizens of the United States was about 40% in 2020.

  • Growth in Prevalence of Neurological Disorders – According to estimates, around 21 million people suffer from neurological problems, of which about 13 million globally require surgery every year.


  • Concerns Associated with the System - Drug degradation, poor absorption, and local discomfort are some of the major concerns associated with the microneedle drug delivery systems. Further, both coated and hollow microneedles possess the risk that the drug will not properly enter the skin and will not be effective. Some of the material used to construct the microneedles cannot be absorbed by the body and any fragments of the needles may irritate.
  • Dearth of Skilled Professionals
  • High Cost of Research and Development in Microneedle Drug Delivery Systems

Global Microneedle Drug Delivery Systems Market Segmentation

The global microneedle drug delivery systems market is segmented and analyzed for demand and supply by material into silicon, metal, and polymer. Out of these segments, the metal segment is anticipated to garner the largest market share over the forecast period, owing to the rising number of cosmetic procedures performed with the adoption of metal microneedles array in cosmetic treatments to treat acne, stretch marks, hair loss, and more. According to statistics, about 15 million cosmetic procedures were performed in 2020, of which 12 million cosmetic procedures are performed on women.

The global microneedle drug delivery system market is segmented and analyzed based on demand and supply by type into solid, hollow, dissolving, and coated. The most important factor that is driving the growth of the microneedle drug delivery system market is the high adoption of various emerging safety issues that include short and long-term impacts for patients, clinicians, healthcare administrators, and regulators. Other important factors include growing research and development initiatives and rising demand for a safer alternative to traditional hypodermic injections.

Our in-depth analysis of the global microneedle drug delivery systems market includes the following segments:

                 By Type

  • Solid
  • Hollow
  • Dissolving
  • Coated

                 By Material

  • Silicon
  • Metal
  • Polymer

                 By Application

  • Dermatology
  • Drug Delivery
  • Pain Management
  • Cancer Therapy
  • Vaccine Delivery

                   By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Academic Institutions
  • Research Institutes

Global Microneedle Drug Delivery System Regional Synopsis

The market in the North American region is anticipated to develop faster owing to the rise in the adoption of highly advanced processes and systems for the manufacture of microneedles and the technical improvements made in microneedle drug delivery. The significant market growth in the area is mostly attributed to the increased knowledge among the populace about the existence of revolutionary microneedle medication delivery systems on the market. The market for microneedle drug delivery system in this region is also anticipated to increase owing to the rising prevalence of chronic diseases among Americans. In the United States, 37.3 million people were determined to have diabetes in 2020, while 96 million adults were found to have pre-diabetes, according to the National Diabetes Statistics Report. About 36 million persons in the United States are anticipated to have chronic renal illnesses in 2020, according to the National Kidney Foundation. According to research from the Centers for Conditions Control and Prevention in 2020, around 15.7 million Americans suffer from a chronic lower respiratory disease. Further, it is anticipated that the prevalence of chronic diseases among Americans will accelerate the growth of the North American microneedle drug delivery systems market. As a result, it is anticipated that growing investments in the healthcare sector and rising awareness of the significance of microneedle drug delivery systems will fuel the market's expansion in this area.

Furthermore, the Asia Pacific region is anticipated to expand quickly owing to factors such as population growth, changing lifestyles, increased patient awareness, and rising per capita spending. Additionally, developing nations such as China and India can strengthen their healthcare systems thanks to economic development and advances in cosmetic items' efficacy.


Top Featured Companies Dominating the Global Microneedle Drug Delivery System Market

  • ICU Medical Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
  • Becton, Dickinson, and Company
  • B. Braun Medical Inc.
  • NanoPass Technologies Ltd
  • Thermo Fisher Scientific
  • Cardinal Health, Inc.
  • 3M
  • TheraJect, Inc.
  • Siemens Healthcare GmbH
  • Raphas Co., Ltd.


In the News

  • ICU Medical Inc. announced that the company has successfully acquired Smiths Medical from Smiths Group plc.

  • Becton, Dickinson, and Company announced that the company will build a new drug delivery manufacturing facility in Zaragoza, Spain to manufacture drug delivery devices for the European Market.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4258
  • Published Date: Feb 17, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of chronic diseases and rising healthcare expenditure are estimated to majorly boost market growth.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023– 2035.

The high cost of research and development of microneedle drug delivery systems is estimated to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are ICU Medical, Inc., Cardinal Health, Inc., 3M, TheraJect, Inc., Siemens Healthcare GmbH, Raphas Co., Ltd., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, material, application, end-user, and by region.

The metal segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying